Skip to main content

NASDAQ:RETA Stock Forecast, Price Targets (Buy or Sell) | RETA Reata Pharmaceuticals Analyst Ratings



If we believe a company would use cash trapped at a foreign subsidiary to meet debt maturities or other liquidity uses at that foreign subsidiary, we would include this cash as a source of liquidity up to the amount of the corresponding use. We generally haircut the cash to be included under sources when a material proportion of a group's cash is held in a different part of the structure than where the debt is located, and we believe the cash may not be fully fungible within the group.

We estimate RETA Reata Pharmaceuticals stock forecast parameters by: Williams %R with ANOVA



RETA Reata Pharmaceuticals Stock Forecast (Buy or Sell) as of 11 Apr 2022 for (n+6m)

Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network with Williams %R and ANOVA. Machine Learning based stock forecast (n+6m) for RETA Reata Pharmaceuticals as below:

Time series to forecast n: 11 Apr 2022 for (n+6m)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %


 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |